U.S.
But the best way to bolster antibodies in people who got J&J’s single-shot vaccine may be to instead give an additional full dose of a messenger RNA vaccine, if a U.S. government-sponsored trial is any indication.
FDA may consider authorization of using one of the U.S.-cleared vaccines to boost initial doses of another, Peter Marks, director of the agency’s Center for Biologics Evaluation ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.